Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1b)

Condition:   Decompensated Cirrhosis Intervention:   Biological: Human Umbilical Cord-derived Mesenchymal Stem Cells Sponsors:   Beijing 302 Hospital;   Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., Hubei, China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials